These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17174236)

  • 1. Reducing the risk of sudden death in heart failure with beta-blockers.
    Adamson PB; Gilbert EM
    J Card Fail; 2006 Dec; 12(9):734-46. PubMed ID: 17174236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
    Kiuchi MG; Nolde JM; Villacorta H; Carnagarin R; Chan JJS; Lugo-Gavidia LM; Ho JK; Matthews VB; Dwivedi G; Schlaich MP
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials.
    Al-Gobari M; El Khatib C; Pillon F; Gueyffier F
    BMC Cardiovasc Disord; 2013 Jul; 13():52. PubMed ID: 23848972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy?
    Squire I
    Heart Fail Rev; 2004 Oct; 9(4):337-45; discussion 347-51. PubMed ID: 15886979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers for preventing sudden cardiac death.
    Giles TD; Basile JN
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
    Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B
    Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
    Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
    Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart failure and sudden death].
    Hirai T; Asanoi H
    Nihon Rinsho; 2005 Jul; 63(7):1155-61. PubMed ID: 16001776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traditional heart failure medications and sudden cardiac death prevention: a review.
    Al Chekakie MO
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):412-26. PubMed ID: 23766358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification.
    Piepoli MF; Capucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):325-33. PubMed ID: 17534251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
    Grimm W; Maisch B
    Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiarrhythmic drug therapy in patients with heart failure].
    Nakamura K; Nishii N; Ohe T
    Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408
    [No Abstract]   [Full Text] [Related]  

  • 19. Sudden cardiac death and heart failure.
    Thompson BS
    AACN Adv Crit Care; 2009; 20(4):356-65. PubMed ID: 19893375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era.
    Reiffel JA
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S45-58. PubMed ID: 15965572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.